editor.mrrjournal@gmail.com +91-87663-44163 E-ISSN: 2584-184X
Submit Paper

MRR

  • Home
  • About Us
    • INDEXING
    • JOURNAL POLIICY
    • PLAGIARISM POLICY
    • PEER REVIEW POLICY
    • OPEN ACCESS POLICY
    • PUBLICATION ETHICS
    • PRIVACY STATEMENT
  • Editorial Board
  • Publication Info
    • Article Submission
    • Submission Guidelines
    • Publication Ethics
    • Journal Policies
    • Aim and Scope
  • Articles & Issues
    • Current Issue
    • Archives
  • Authors Instruction
  • Contact

MRR Journal

Indian Journal of Modern Research and Reviews, 2026; 4(9):277-283

Machine Learning in Personalized Drug-Dose Optimization: A Review

Authors: Avinash Bajpai; Sachin Sharma;

1. Assistant Professor, I.T.S College of Pharmacy, Muradnagar, Ghaziabad, Uttar Pradesh, India

2. Assistant Professor, I.T.S College of Pharmacy, Muradnagar, Ghaziabad, Uttar Pradesh, India

Paper Type: Research Paper
Article Information
Received: 2026-07-05   |   Accepted: 2026-08-10   |   Published: 2026-09-29
Abstract

Dosing decisions for narrow-therapeutic-index and highly variable drugs have historically relied on population-based nomograms, therapeutic drug monitoring, and clinician heuristics, which frequently under- or over-dose individual patients. Machine learning (ML) offers a data-driven alternative capable of integrating genomic, physiological, and longitudinal clinical information to individualize dosing. This review synthesizes recent literature on ML-based precision dosing across five therapeutic domains—anticoagulation, antibiotics, immunosuppression, oncology, and diabetes—and examines the major methodological families in use: classical supervised learning, deep learning, neural ordinary differential equations, and reinforcement learning. Across domains, ML models consistently outperform linear pharmacogenetic and population pharmacokinetic algorithms in retrospective accuracy, and reinforcement learning shows promise for sequential, adaptive dosing in closed-loop systems such as the artificial pancreas. However, clinical translation remains limited by small and non-diverse training cohorts, weak external validation, limited interpretability of complex models, and an evolving regulatory landscape for adaptive software a    s a medical device. Emerging approaches—hybrid mechanistic-ML models, neural ODEs, explainable AI, and patient-specific digital twins—are discussed as pathways toward safer, more transparent, and clinically actionable dose-individualization tools. The review concludes that realizing the potential of ML in precision dosing will require prospective validation, standardized reporting, and close integration with pharmacometric principles rather than treating ML as a replacement for mechanistic understanding.

Keywords

machine learning, precision dosing, pharmacokinetics, reinforcement learning, model-informed precision dosing, personalized medicine

How to Cite

Avinash Bajpai, Sachin Sharma. Machine Learning in Personalized Drug-Dose Optimization: A Review. Indian Journal of Modern Research and Reviews. 2026; 4(9):277-283

Download PDF

Useful Links

  • Home
  • About us
  • Editorial Board
  • Current Issue
  • All Issues
  • Submit Paper

Indexing

MRR

Contact Us

Phone: +91-87663-44163
Email: editor.mrrjournal@gmail.com | editor.mrrjournal@gmail.com

© Copyright MRR 2023. All Rights Reserved